0001362703 2022-10-01 2023-09-30 0001362703 2023-03-31 0001362703 2024-01-28 iso4217:USD shares iso4217:USD shares pure utr:sqft true FY 0001362703 10-K/A true 2023-09-30 --09-30 2023 false 000-52218 Theralink Technologies, Inc. NV 20-2590810 15000 W. 6th Avenue Suite 400 Golden CO 80401 (888) 585-4923 Common Stock, Par Value $0.0001 No No Yes Yes Non-accelerated Filer true false false false false 2500000 6151499919 106 Salberg & Company, P.A Boca Raton, Florida This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K (the “2023 Form 10-K”) of Theralink Technologies, Inc. (the “Company”) for the year ended September 30, 2023 (“Fiscal 2023”), as filed with the Securities and Exchange Commission (the “SEC”) on January 5, 2024. We are filing this Amendment to amend Part III of the 2023 Form 10-K to include the information required by and not included in Part III of the 2023 Form 10-K because we do not intend to file our definitive proxy statement within 120 days of the end of Fiscal 2023.